1. Lou A, Elnenaei M, Liu E, et al. Evaluation of a novel albumin platelet product (APP) fibrosis index and three ...

More than half of patients in a Phase III clinical trial who received a limited course of the experimental monoclonal ...

ITP is an autoimmune condition where the body’s immune cells mistakenly attack platelets, the blood cells responsible for clotting.

Key Takeaways An experimental drug can help many with a rare autoimmune bleeding conditionMore than half of people with immune thrombocytopenia wound up with healthy platelet levels after treatment ...

The man’s unchecked bleeding was a mystery for years before a scan revealed the cause.

Time is critical for patients this December. The American Red Cross urges donors to make an appointment to give blood or ...

Dengue cases in Tamil Nadu rise, but improved awareness and protocols lead to fewer complications and deaths this year.

A routine Complete Blood Count (CBC) offers vital insights into your health, revealing levels of red blood cells for oxygen transport, white blood cel ...

An experimental monoclonal antibody called ianalumab had promising results for more than half of patients with primary immune thrombocytopenia enrolled in a phase 3 trial, according to data published ...

More than half of patients in a Phase III clinical trial who received a limited course of the experimental monoclonal antibody ianalumab for primary immune thrombocytopenia (ITP), an autoimmune ...

This article was reviewed by Felix Gussone, MD. How to Read Blood Test Results: What “Normal” Really Means for Your Health ...